Sarah Kurz

As the Executive Vice President of PTx, Sarah chairs the company’s Executive Leadership Team and leads the Commercial and Medical Affairs functions. Prior to joining PTx, Sarah served as Vice President of Sales and Operations at Merrimack Pharmaceuticals where she built the company’s commercial infrastructure and launched the company’s first commercial product in pancreatic cancer. At Ipsen Biopharmaceuticals, Sarah oversaw the company’s neurology and endocrinology product portfolios, served as a member of the North American Executive Team, and led the restructuring of Ipsen’s U.S. business. Prior to that, Sarah oversaw MacroGenics’ global late-stage development program in juvenile diabetes and managed the company’s global alliance with Eli Lilly. She holds an undergraduate degree from Bowdoin College and both an MBA and MPH from Emory University.